| abstract |
Inflammatory diseases associated with the 5-lipoxygenase pathway, or rheumatoid arthritis, cystic fibrosis, psoriasis, inflammatory bowel syndrome, gastritis, Crohn's disease, ileocolitis, total enteritis, hemorrhagic rectal colitis and inflammation Provision of therapeutic agents for the treatment of ulcerative colitis. 2-[[1- [1-[(4-Fluorophenyl) methyl] -1H-benzimidazol-2-yl] -4-piperidyl] methylamino] -4-pyrimidinol or 2-[[1 -[1-[(4-Fluorophenyl) methyl] -1H-benzimidazol-2-yl] -4-piperidyl] methylamino] pyrimidin-4 (1H) -one and its pharmaceutically acceptable Salt. [Selection figure] None |